Strong outcomes seen in terms of weight loss, with lower doses of semaglutide used
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
By I. Edwards HealthDay ReporterFRIDAY, May 23, 2025 (HealthDay News) — A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access …